About Almac Group
Almac Group is a Healthcare company based in Craigavon (United Kingdom) founded in 2001. Integrated CDMO services for biopharma RD and manufacturing are offered. Almac Group has raised $338.8 million across 15 funding rounds from investors including Gates Foundation, European Union and Invest Northern Ireland. Almac Group has completed 2 acquisitions, including Arran Chemical and BioClin Labs. Almac Group was last valued at $373.1 million in May 2019. Its chief executive, as recorded, is Alan Armstrong. Its website almacgroup.com draws about 63 thousand monthly visits. Almac Group offers products and services including Genomic Services, API Development, and Clinical Trial Services. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is ALMAC GROUP LIMITED.
Company details
Almac Group was founded in 2001 and operates as a contract development and manufacturing organization in the biopharmaceutical sector. Services including biomarker discovery, API production, formulation development, clinical trial supplies, companion diagnostics, analytical support, and commercial manufacturing are provided. Facilities are maintained in Europe, North America, and Asia, with headquarters located in Craigavon, United Kingdom.
- Headquarters Craigavon, United Kingdom
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website almacgroup.com
- Social LinkedIn X YouTube
- Legal Name Almac Group Limited
- Date of Incorporation 20 Sep, 2001
- Jurisdiction CRAIGAVON
- Total Equity Funding$338.8M (USD)
in 15 rounds
- Latest Funding Round$416.67K (USD), Grant
Sep 2022
- InvestorsGates Foundation
& 4 more
- Investments & AcquisitionsArran Chemical
& 1 more
Products & Services of Almac Group
Almac Group offers a comprehensive portfolio of products and services, including Genomic Services, API Development, and Clinical Trial Services.
Offers testing and analysis for biomarkers in clinical trials
Provides manufacturing solutions for drug substances
Manages supply and logistics for trials
Apps and channels of Almac Group
its YouTube channel AlmacVideo has 654 subscribers and 30 videos.
Videos from Almac Group
The most watched videos on Almac Group's YouTube channel, AlmacVideo (654 subscribers). Click a video to play it here.
More on AlmacVideo.
Funding Insights of Almac Group
Almac Group has successfully raised a total of $338.8M across 15 strategic funding rounds. The most recent funding activity was a Grant round of $416.67 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $338.8M
- Total Rounds 15
- Last Round Grant — $416,674
- First Round $9.3M
(May 2007)
- Investors Count 5
Latest 10 of 15 funding rounds of Almac Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $416,674 | Grant | – | – | |
| Jan 2021 | $2.7M | Grant | – | – | |
| May 2020 | $288,000 | Grant | – | – | |
| Apr 2020 | $332,063 | Grant | – | – | |
| Dec 2019 | $1M | Grant | – | – | |
| May 2019 | $64M | Series D | $373.1M | – | – |
| Apr 2018 | $107M | Series D | $421.94M | – | – |
| Jan 2017 | $337,270 | Grant | – | – | – |
| Nov 2016 | $72.8M | Series C | $••••• | – | – |
| Nov 2013 | $51.8M | Series C | $••••• | Genomic Health | – |
| Date | Valuation | Stage |
|---|---|---|
| May 2019 | $373.1M | •••••••• |
| Apr 2018 | $421.94M | •••••••• |
| Nov 2016 | $••••• | •••••••• |
| Nov 2013 | $••••• | •••••••• |
| Mar 2013 | $••••• | •••••••• |
| Nov 2011 | $••••• | •••••••• |
| Feb 2009 | $••••• | •••••••• |
| Jul 2008 | $••••• | •••••••• |
Full valuation and stage history of Almac Group
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $373.1M (May 2019). 5 investors in total: 5 institutional.
Investors in Almac Group
Almac Group has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, European Union and Invest Northern Ireland.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Foundation fund focused on science & technology in Ireland | 2000 | sfi.ie | Dublin, Ireland | |
Business support and investment attraction services are provided to enterprises. | 2002 | investni.com | Belfast, United Kingdom | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
Genomic-based diagnostic tests for cancer prognosis are developed and provided. | 2000 | genomichealth.com | Redwood City, United States |
Investor details for Almac Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Almac Group
68 people are tracked at Almac Group (35 in leadership, 2 in board & advisors, 31 in team).
| Name | Role | Group |
|---|---|---|
Alan Armstrong | CEO & Chairman | Leadership |
John Walter Irvine | Director | Leadership |
Colin Hayburn | Solicitor | Leadership |
Stephen Alexander Barr | MD | Leadership |
Garrett H. | Director, Strategic And Key Accounts | Leadership |
Stephen Barr | President & Managing Director, Almac Sciences & Almac Discovery | Leadership |
Valarie Higgins | President & Managing Director, Almac Clinical Technologies | Leadership |
Gareth Maguire | Director Of Business Development | Leadership |
Celine Bradley | Deputy Managing Director & Global VP of Operations, Almac Clinical Services | Leadership |
Simon Hamilton | VP Business Development - Almac Sciences | Leadership |
Graeme McBurney | COO | Leadership |
Leah Simke | Business Development Director | Leadership |
Tom Moody | Vice President Of API Development & Commercialisation | Leadership |
James Hurst | VP Operations & Charnwood Site Head, Almac Pharma Services | Leadership |
Ivan Waide | Vice President, IP & Data | Leadership |
Michelle Foust | Director Of New Product Development | Leadership |
Andrew Gemmell | Head Of Quality, Almac Pharma Services, Charnwood | Leadership |
Paul Harkin | President & Managing Director, Almac Diagnostic Services | Leadership |
Grainne Hughes | VP Business Support Operations - Almac Pharma Services | Leadership |
Jonathan Loughery | Associate Director | Leadership |
48 more people are available in the full profile.
Complete people profiles for Almac Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Almac Group
Almac Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Arran Chemical and BioClin Labs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
GLP and cGMP certified contract research laboratory | bioclinlabs.com | Athlone, Ireland | 2003 | Nov 2017 | •••• | |
Fine chemical company specializing in the development of products for a wide range of industries | arranchemical.ie | Athlone, Ireland | 1984 | Nov 2015 | •••• |
Complete acquisition details for Almac Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Almac Group
6 dated milestones of Almac Group across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Almac Group is founded.
- Funding First funding round of $9.3M.
- Milestone Reaches Minicorn status.
- Acquisition Acquires Arran Chemical.
- Acquisition Acquires BioClin Labs.
- Funding Latest funding round, Grant, of $417K.
Web traffic of Almac Group
The website of Almac Group (almacgroup.com) receives about 63.1K visits a month and ranks #547,621 among all websites worldwide, #571 in Biotechnology and Pharmaceuticals.
- Monthly visits63.1K
▲ 8.4% vs previous month
- Unique visitors26.1K
per month
- Global rank#547,621
among all websites
- Category rank#571
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit2.3
- Average visit44 sec
- DevicesDesktop 35% · Mobile 65%
Websites whose visitors overlap most with Almac Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| iconplc.com | 100% | 476.9K | #92,950 | View details | |
absg.com | absg.com | 99% | #8,286,562 | – | |
| ardena.com | 96% | 12.2K | #1,448,848 | View details | |
| catalent.com | 92% | 116.7K | #338,870 | View details | |
| patheon.com | 89% | 89.1K | #488,648 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 38 similar websites and full traffic analytics for Almac Group
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 38 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Almac Group
Complete news archive for Almac Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Almac Group
Almac Group was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Almac Group is headquartered in Craigavon, United Kingdom. It is registered at Craigavon, Northern Ireland, United Kingdom.
Alan Armstrong is the CEO of Almac Group, as recorded in our data.
Almac Group is a funded company, having raised a total of $338.8M across 15 funding rounds to date. The company's 1st funding round was a Series C of $51.8M, raised on May 2007.
Almac Group was founded in 2001 and operates as a contract development and manufacturing organization in the biopharmaceutical sector. Services including biomarker discovery, API production, formulation development, clinical trial supplies, companion diagnostics, analytical support, and commercial manufacturing are provided. Facilities are maintained in Europe, North America, and Asia, with headquarters located in Craigavon, United Kingdom.
Almac Group offers Genomic Services, API Development, and Clinical Trial Services.
Almac Group has made 2 acquisitions, including Arran Chemical, and BioClin Labs.
Almac Group has 5 investors. Key investors include Gates Foundation, European Union, Invest Northern Ireland, Genomic Health, and Science Foundation Ireland.
The valuation of Almac Group is $373.1M as of May 2019.
Almac Group operates through Almac Group Limited.